Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun;53(3):485-487.
doi: 10.1016/j.jmii.2020.03.003. Epub 2020 Mar 10.

A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic

Nan-Yao Lee  1 , Chia-Wen Li  2 , Huey-Pin Tsai  3 , Po-Lin Chen  1 , Ling-Shan Syue  2 , Ming-Chi Li  2 , Chin-Shiang Tsai  2 , Ching-Lung Lo  2 , Po-Ren Hsueh  4 , Wen-Chien Ko  5
Affiliations
Case Reports

A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic

Nan-Yao Lee et al. J Microbiol Immunol Infect. 2020 Jun.

Abstract

A 46-year-old woman presented to the emergency department with 2-day fever and cough at seven days after returning from Macau. COVID-19 and pneumonia was diagnosed based on the positive real-time RT-PCR tests for oropharyngeal swab samples and the presence of anti-SARS-COV-2 IgG starting from the illness day 11 and post-exposure 18-21 days.

Keywords: COVID-19; IgG; Macau; Novel coronavirus; Pneumonia; SARS-CoV-2; Serology; Taiwan.

PubMed Disclaimer

Figures

Fig. 1
Figure 1
Chest X-ray films of the case of COVID-19. (A) Hospital day 1: increased pulmonary infiltrations, esp. in left lung field (white arrows). (B) Hospital day 14: Resolution of pulmonary infiltrates at left lung field (white arrows).
See this image and copyright information in PMC

References

    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28 doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020 Feb 17:105924. doi: 10.1016/j.ijantimicag.2020.105924. - DOI - PMC - PubMed
    1. Lai C.C., Liu Y.H., Wang C.Y., Wang Y.H., Hsueh S.C., Yen M.Y. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths. J Microbiol Immunol Infect. 2020;53:404–412. doi: 10.1016/j.jmii.2020.02.012. - DOI - PMC - PubMed
    1. Huang W.H., Teng L.C., Yeh T.K., Chen Y.J., Lo W.J., Wu M.J. 2019 Novel coronavirus disease (COVID-19) in Taiwan: reports of two cases from Wuhan, China. J Microbiol Immunol Infect. 2020;53:481–484. doi: 10.1016/j.jmii.2020.02.009. - DOI - PMC - PubMed
    1. Li Z., Yi Y., Luo X., Xiong N., Liu Y., Li S. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020 Feb 27 doi: 10.1002/jmv.25727. - DOI - PMC - PubMed

Publication types

Substances